Highlights from the 2019 ASCO Annual Meeting - Gastrointestinal Cancers - a podcast by OncologyEducation
from 2019-08-20T14:52:52
::
::
In this episode, we'll listen to Dr. Scott Berry, Dr. Marc Peeters and Dr. Sharlene Gill, discuss the important trials presented at ASCO 2019.
08:20 - Apact Trial
16:35 - Phase 3 Trial of 1st Line Chemo vs Pembrolizumab vs Chemo + Pembrolizumab for Metastatic Gastric CA
24:15 - Phase 3 Trial of 2nd Line Pembrolizumab vs Placebo for HCC
30:26 - ABC-06
35:35 - IDEA Study (High Risk Stage 2 Patients)
46:19 - Foxtrot Trial
Further episodes of Best of Oncology Podcast Series
Further podcasts by OncologyEducation
Website of OncologyEducation